262 related articles for article (PubMed ID: 24009280)
1. Warfarin-related nephropathy is the tip of the iceberg: direct thrombin inhibitor dabigatran induces glomerular hemorrhage with acute kidney injury in rats.
Ryan M; Ware K; Qamri Z; Satoskar A; Wu H; Nadasdy G; Rovin B; Hebert L; Nadasdy T; Brodsky SV
Nephrol Dial Transplant; 2014 Dec; 29(12):2228-34. PubMed ID: 24009280
[TBL] [Abstract][Full Text] [Related]
2. Oral warfarin and the thrombin inhibitor dabigatran increase blood pressure in rats: hidden danger of anticoagulants?
Ware KM; Vance JC; Muni N; Hebert LA; Satoskar AA; Nadasdy G; Ivanov I; Nadasdy T; Rovin BH; Brodsky SV
Am J Hypertens; 2015 Feb; 28(2):182-9. PubMed ID: 25023204
[TBL] [Abstract][Full Text] [Related]
3. N-acetylcysteine ameliorates acute kidney injury but not glomerular hemorrhage in an animal model of warfarin-related nephropathy.
Ware K; Qamri Z; Ozcan A; Satoskar AA; Nadasdy G; Rovin BH; Hebert LA; Nadasdy T; Brodsky SV
Am J Physiol Renal Physiol; 2013 Jun; 304(12):F1421-7. PubMed ID: 23576637
[TBL] [Abstract][Full Text] [Related]
4. Role of glomerular filtration rate-modifying drugs in the development of anticoagulant-related nephropathy.
Medipally AK; Xiao M; Rovin BH; Satoskar AA; Ivanov I; Qaisar S; Brodsky SV
Physiol Rep; 2021 Jan; 9(1):e14697. PubMed ID: 33427414
[TBL] [Abstract][Full Text] [Related]
5. Dabigatran-induced anticoagulant-related nephropathy with undiagnosed IgA nephropathy in a patient with normal baseline renal function.
Ikeda M; Tanaka M; Shimoda S; Saita H; Nishikawa S; Shimada H; Taniguchi K; Hagihara K; Iwanari S; Takeoka H
CEN Case Rep; 2019 Nov; 8(4):292-296. PubMed ID: 31347098
[TBL] [Abstract][Full Text] [Related]
6. Role of protease-activated receptor-1 (PAR-1) in the glomerular filtration barrier integrity.
Medipally A; Xiao M; Biederman L; Satoskar AA; Ivanov I; Rovin B; Parikh S; Kerlin BA; Brodsky SV
Physiol Rep; 2022 Aug; 10(15):e15343. PubMed ID: 35923090
[TBL] [Abstract][Full Text] [Related]
7. 5/6 nephrectomy as a validated rat model mimicking human warfarin-related nephropathy.
Ozcan A; Ware K; Calomeni E; Nadasdy T; Forbes R; Satoskar AA; Nadasdy G; Rovin BH; Hebert LA; Brodsky SV
Am J Nephrol; 2012; 35(4):356-64. PubMed ID: 22473220
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulant Related Nephropathy Only Partially Develops in C57BL/6 Mice: Hematuria Is Not Accompanied by Red Blood Cell Casts in the Kidney.
Medipally AK; Xiao M; Qaisar S; Satoskar AA; Ivanov I; Rovin B; Brodsky SV
Front Med (Lausanne); 2020; 7():617786. PubMed ID: 33598467
[TBL] [Abstract][Full Text] [Related]
9. Oral anticoagulants and risk of nephropathy.
Narasimha Krishna V; Warnock DG; Saxena N; Rizk DV
Drug Saf; 2015 Jun; 38(6):527-33. PubMed ID: 25913726
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) trial analysis.
Hijazi Z; Hohnloser SH; Oldgren J; Andersson U; Connolly SJ; Eikelboom JW; Ezekowitz MD; Reilly PA; Siegbahn A; Yusuf S; Wallentin L
Circulation; 2014 Mar; 129(9):961-70. PubMed ID: 24323795
[TBL] [Abstract][Full Text] [Related]
11. Hemorrhagic complications in emergency department patients who are receiving dabigatran compared with warfarin.
Berger R; Salhanick SD; Chase M; Ganetsky M
Ann Emerg Med; 2013 Apr; 61(4):475-9. PubMed ID: 23522810
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulant-related nephropathy: a case report and review of the literature of an increasingly recognized entity.
Kalaitzidis RG; Duni A; Liapis G; Balafa O; Xiromeriti S; Rapsomanikis PK; Elisaf MS
Int Urol Nephrol; 2017 Aug; 49(8):1401-1407. PubMed ID: 28161838
[TBL] [Abstract][Full Text] [Related]
13. My Bleeding Nephrons!
Li J; Padala SA; Hinnant G; Vakiti A; Mohammed A
J Investig Med High Impact Case Rep; 2019; 7():2324709619858126. PubMed ID: 31216916
[TBL] [Abstract][Full Text] [Related]
14. Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases.
Brodsky SV; Satoskar A; Chen J; Nadasdy G; Eagen JW; Hamirani M; Hebert L; Calomeni E; Nadasdy T
Am J Kidney Dis; 2009 Dec; 54(6):1121-6. PubMed ID: 19577348
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.
Graham DJ; Reichman ME; Wernecke M; Zhang R; Southworth MR; Levenson M; Sheu TC; Mott K; Goulding MR; Houstoun M; MaCurdy TE; Worrall C; Kelman JA
Circulation; 2015 Jan; 131(2):157-64. PubMed ID: 25359164
[TBL] [Abstract][Full Text] [Related]
16. The importance of postapproval data for dabigatran.
Redberg RF
JAMA Intern Med; 2015 Jan; 175(1):25. PubMed ID: 25365377
[No Abstract] [Full Text] [Related]
17. Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis.
Schulman S; Kakkar AK; Goldhaber SZ; Schellong S; Eriksson H; Mismetti P; Christiansen AV; Friedman J; Le Maulf F; Peter N; Kearon C;
Circulation; 2014 Feb; 129(7):764-72. PubMed ID: 24344086
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulant-related nephropathy: Focus on novel agents. A review.
Zakrocka I; Załuska W
Adv Clin Exp Med; 2022 Feb; 31(2):165-173. PubMed ID: 35212199
[TBL] [Abstract][Full Text] [Related]
19. Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin.
Zalesak M; Siu K; Francis K; Yu C; Alvrtsyan H; Rao Y; Walker D; Sander S; Miyasato G; Matchar D; Sanchez H
Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):567-74. PubMed ID: 23922182
[TBL] [Abstract][Full Text] [Related]
20. Management and outcomes of major bleeding during treatment with dabigatran or warfarin.
Majeed A; Hwang HG; Connolly SJ; Eikelboom JW; Ezekowitz MD; Wallentin L; Brueckmann M; Fraessdorf M; Yusuf S; Schulman S
Circulation; 2013 Nov; 128(21):2325-32. PubMed ID: 24081972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
